Core Laboratories (CLB) Other Non-Current Liabilities (2022 - 2026)

Core Laboratories' Other Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $15.9 million for Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 24.41% year-over-year to $15.9 million in Q1 2026; TTM through Mar 2026 was $15.9 million, a 24.41% decrease from a year earlier, with the FY2025 full-year figure at $15.8 million, down 23.56% from the prior year.
• Other Non-Current Liabilities held at $15.9 million in Q1 2026 per CLB's latest filing, from $15.8 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $21.9 million in Q2 2025 and bottomed at $15.8 million in Q4 2025.
• The 5-year median for Other Non-Current Liabilities is $20.2 million (2024), against an average of $19.7 million.
• Across the five-year window, Other Non-Current Liabilities rose 7.59% in 2024 and slipped 24.41% in 2026, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $20.9 million in 2022, then retreated by 4.04% to $20.0 million in 2023, then gained by 3.45% to $20.7 million in 2024, then dropped by 23.56% to $15.8 million in 2025, then advanced by 0.13% to $15.9 million in 2026.
• Per Business Quant, the three latest CLB Other Non-Current Liabilities figures stand at $15.9 million (Q1 2026), $15.8 million (Q4 2025), and $21.4 million (Q3 2025).